% Expired Patents = 75.0

Forward Citations = 17

Loading Chart...

9 inventors (with patents filed for the assignee):

Gordon Dougan (1 out of 18 patents)

Elizabeth Janina Davidson (1 out of 1 patent)

Fiona Craig (1 out of 1 patent)

4. Andrew John McGlashan Richards (1 out of 11 patents)

5. Steven Neville Chatfield (1 out of 10 patents)

6. Nicholas Robert Pope (1 out of 4 patents)

7. Marianne Langston (1 out of 3 patents)

8. Mark Sydenham (1 out of 1 patent)

9. Hooshang Shahriari Zavareh (1 out of 9 patents)

4 patents: Sort by Forward Citations

1. 7384959 - Treatment of convulsive states (2008-06-10),

2. 7267949 - Composition comprising methylphenidate and another drug (2007-09-11),

3. 7164025 - Manufacture of single isomer methylphenidate (2007-01-16),

4. 6905691 - Vaccines containing attenuated bacteria (2005-06-14),

Company Overview

Celltech Pharma Europe Limited is a pharmaceutical company specializing in the development and commercialization of innovative drugs for the treatment of various diseases. Our focus is on research and development of cutting-edge therapies to address unmet medical needs and improve patient outcomes. With a strong commitment to quality and excellence, we aim to make a positive impact on healthcare worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#43 in Berkshire

#3,869 in United Kingdom

Berkshire, United Kingdom

Celltech Pharma Europe Limited

Forward Citations = 17

9 inventors:

Gordon Dougan (1 out of 18 patents)

Elizabeth Janina Davidson (1 out of 1 patent)

Fiona Craig (1 out of 1 patent)

4. Andrew John McGlashan Richards (1 out of 11 patents)

5. Steven Neville Chatfield (1 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Celltech Pharma Europe Limited. Retrieved from https://idiyas.com/company/celltech-pharma-europe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]